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Abstract 
Under appropriate conditions, neural tissues transplanted into the adult mammalian brain can 
survive, integrate and function so as to influence the behaviour of the host, opening the prospect of 
repairing neuronal damage and alleviating symptoms associated with neuronal injury or 
neurodegenerative disease. Alternative mechanisms of action have been postulated : non-specific 
effects of surgery; neurotrophic and neuroprotective influences on disease progression and host 
plasticity; diffuse or locally-regulated pharmacological delivery of deficient neurochemcials, 
neurotransmitters or neurohormones; restitution of the neuronal and glial environment necessary 
for proper host neuronal support and processing; promoting local and long distance host and graft 
axon growth; formation of reciprocal connections and reconstruction of local circuits within the host 
brain; up to full integration and reconstruction of fully functional host neuronal networks. Analysis 
of neural transplants in a broad range of anatomical systems and disease models, on simple and 
complex classes of behavioural function and information processing, have indicated that all of these 
alternative mechanisms are likely to contribute in different circumstances. Thus, there is not a 
simple or typical mode of graft function; rather grafts can and do function in multiple ways, specific 
to each particular context. Consequently, to develop an effective cell-based therapy, multiple 
dimensions must be considered: the target disease pathogenesis; the neurodegenerative basis of 
each type of physiological dysfunction or behavioural symptom; the nature of the repair required to 
alleviate or remediate the functional impairments of particular clinical relevance; and identification 
of a suitable cell source or delivery system, along with the site and method of implantation, that can 
achieve the sought for repair and recovery. 
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1. INTRODUCTION  
The transplantation of neural cells and tissues into the mammalian central nervous system has been 
a topic of scientific investigation since the late nineteenth century, and evidence for successful 
engraftment using a variety of immature tissue sources, implanted into a variety of central and 
peripheral targets, was achieved from multiple labs during the first half of the twentieth century 
(Björklund & Stenevi, 1985a, Dunnett, 2010). However, it was only in the 1970s that the first reliable 
methods for neural transplantation into the adult (Stenevi et al., 1976) or neonatal (Das & Altman, 
1971, Lund & Hauschka, 1976) brain were introduced. 
Once these techniques were established, many investigators began using this new tool for the 
anatomical analysis of nervous system development, regeneration and plasticity (see Björklund and 
Stenevi, 1985; Sladek & Gash, 1984; Wallace & Das, 1983 for early overviews of this emerging field). 
In addition, there rapidly developed a parallel interest in the functional capacity of transplanted cells 
– specifically, whether disability resulting from neuronal loss or circuit damage in the adult CNS 
might be alleviated by cell transplantation aimed to replace the lost neurons and/or repair their 
connections. Within a five year period at the turn of the 1980s functional recovery from mechanical, 
toxic and genetic lesions of the central nervous system was seen in a multiplicity of model systems. 
These included alleviation of motor symptoms in parkinsonian rats by transplants of embryonic 
dopamine neurons (Björklund & Stenevi, 1979, Perlow et al., 1979, Björklund et al., 1980); 
normalisation of polyuria and polydipsia in diabetic rats by transplants of vasopressin-secreting 
hypothalamic neurons (Gash et al., 1980); restitution of normal sexual function in hypogonadal mice 
by transplants of GnRH-secreting hypothalamic neurons (Krieger et al., 1982); restitution of diurnal 
rhythms in SCN lesioned or genetic mutant mice (Drucker-Colín et al., 1984, Ralph et al., 1990); 
normalisation of hippocampus-dependent maze learning by cholinergic neurons in the denervated 
or aging hippocampus (Dunnett et al., 1982, Low et al., 1982, Gage et al., 1984); and alleviation of 
both motor and cognitive deficits associated with striatal lesion models of Huntington’s disease (HD) 
by embryonic striatal grafts (Deckel et al., 1983, Isacson et al., 1984, 1986, Dunnett et al., 1988). 
In all these models, transplant-derived recovery was seen to be associated with anatomical survival 
of neurons exhibiting an appropriate morphology and transmitter type to replace the lost cells, 
outgrowth of axons making synaptic connections with appropriate host targets, and neurochemical 
and electrophysiological restitution of relevant neurotransmitter signalling. With the enthusiasm of 
successes seen in such widely diverse systems, it was therefore entirely natural to conclude that any 
observed functional recovery could be attributed to replacement of lost neurons and repair of the 
damaged host neural circuitry. However, even from an early stage, it was noted that all successful 
models involved transplantation of neuronal populations involved in “diffuse” modes of 
communication – for example, the dopamine innervation of the striatum, or the cholinergic, 
noradrenergic and serotonergic innervation of hippocampus and cortex, all of which have been 
considered as components of the diffuse reticular forebrain activating systems. Following a similar 
reasoning, hypothalamic, adrenal and other neuroendocrine neurons are all involved in secretion of 
blood-borne neuro-hormonal signalling molecules. Consequently, a clear strand of scepticism soon 
emerged about whether similar recovery could ever be achieved by cell replacement in more 
precisely wired “point-to-point” systems such as those involved in cortico-thalamic, visual system, 
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cerebellar or spinal cord communication (Sotelo & Alvarado-Mallart, 1987, 1991, Worthington & 
Harvey, 1990).  
The purpose of this introductory chapter is to pursue this topic further and outline our growing 
understanding of the diverse range of influences that transplanted cells may exert over the host 
nervous system and the behavioural function of the host animal. We have sought to identify the 
different types of integration and reconstruction that may optimise functional repair, at the same 
time as we recognise opportunities for therapeutic efficacy that do not require full reconstruction of 
damaged circuitry. This then provides a conceptual framework for the chapters that follow, which 
develop alternative themes and strategies for functional cell-based repair in more detail. 
 
2. ALTERNATIVE MECHANISMS OF FUNCTIONAL RECOVERY 
Our recognition of the need to identify multiple mechanisms of graft function first emerged from 
comparison of the behavioural recovery that was seen when grafting embryonic ventral 
mesencephalic (“nigral”) and ganglionic eminence (“striatal”) tissues within the basal ganglia in 
rodent lesion models of Parkinson´s disease (PD) and Huntington´s disease (HD), respectively. Even 
though the two models involve disruption and repair within the same anatomical circuits of the 
basal ganglia, and assessed functionally using the same set of behavioural tests, the actual profiles of 
functional recovery turned out to be very different in the two models (Björklund et al., 1987). 
Notably, both nigral grafts in the 6-OHDA-lesioned dopamine-depleted parkinsonian striatum and 
striatal grafts in the excitotoxically lesioned HD-like striatum are capable of alleviating simple motor 
deficits, such as hypo/hyperactivity after bilateral lesions and turning behaviour in animals with 
lesions restricted to one hemisphere. However, whereas the nigral grafts appear to have a simpler 
task in hand (to replace a single diffuse dopaminergic input to the denervated striatum, leaving all 
other aspects of striatal circuitry intact) than the striatal grafts (where the loss of intrinsic striatal 
neurons following excitotoxic lesion destroys interneurons, projection neurons and their circuit 
connections), yet the striatal grafts were able to alleviate a broader range of cognitive, complex 
motor, and motor learning functions, such as in skilled paw reaching (Dunnett et al., 1987, 1988, 
Montoya et al., 1990), that are relatively resistant to alleviation by the nigral grafts.  
Insert Figure 1. about here 
The most obvious difference between the two models (see Figure 1) is that to be fully effective 
nigral grafts require ectopic placement of the grafted dopamine neurons into the denervated striatal 
target. Transplants of fetal dopamine neurons into the lesioned substantia nigra (from where the 
host dopamine neurons were lost) survive and can be made to reconnect to the denervated 
forebrain targets in a remarkably precise manner (Wictorin et al. 1992; Thompson et al. 2009; 
Grealish et al. 2013), but the functional recovery obtained using this approach has so far been quite 
limited (Björklund et al., 1983). Conversely, to be effective, striatal grafts are replaced homotopically 
into the striatal area of host cell loss, from where they are seen to project long distance axons to the 
host pallidum and nigra (Wictorin et al., 1990b, Wictorin et al., 1991), as well as to attract 
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regenerative sprouting of adult host cortical, thalamic and nigral afferents that have lost their 
intrinsic targets by the excitotoxic lesion (Wictorin, 1992).  
Thus, different mechanisms of action for the two graft types are suggested, even when involving the 
same implantation site and functional behaviours. To be maximally effective, nigral grafts are 
implanted ectopically so as to restore dopaminergic neurotransmission in the reinnervated striatal 
targets (Figure 1C), which may act to provide local reactivation similar to that provided by L-dopa or 
dopaminergic agonists in patients. Such grafts may provide dopamine replacement at more 
physiological levels targeted explicitly at locally regulated synaptic sites than can be readily achieved 
by a synthetic local drug delivery system (Hargraves & Freed, 1987), but the underlying mechanism 
is still essentially pharmacological. In their ectopic location, both anatomical tracing studies as well 
as electrophysiological recordings have provided evidence that the dopamine neurons grafted into 
the dopamine-denervated striatum receive afferent inputs from the host – striatum, frontal cortex 
and raphé nuclei, in particular (Doucet et al., 1989, Fisher et al., 1991, Sorensen et al., 2005). But the 
full complement of inputs available to the nigral dopamine neurons in their normal midbrain 
locations is clearly not restored in such ectopic grafts.  
The excitotoxic striatal model is quite different in that there are no pharmacological agents akin to L-
dopa in PD that can alleviate the overt motor or cognitive symptoms of intrinsic striatal lesion or HD. 
The striatum has a central role in the selection and initiation of cortically-derived plans for actions, 
and dysfunction following lesions, or in the human disease, is considered to be attributable to an 
essential disconnection of the cortico-striatal (in particular fronto-striatal) circuits that underpin 
goal-directed action (Rosvold, 1972). The observation that homotopic striatal grafts provide effective 
alleviation of motor, motor learning and cognitive deficits in excitotoxic lesioned rats corroborates 
the hypothesis that homotopically-placed striatal grafts can restore afferent and efferent circuitry in 
the adult nervous system (Figure 1E), the substrates for which have been amply demonstrated at 
light microscopic (Wictorin, 1992), biochemical (Campbell et al., 1993, Sirinathsinghji et al., 1988, 
Sirinathsinghji et al., 1993), electrophysiological (Rutherford et al., 1987, Xu et al., 1991, Nakao et al., 
1999) and ultrastructural (Clarke & Dunnett, 1993) levels of circuit analysis. Moreover, it is notable 
that striatal grafts placed into the globus pallidus (comparable to the ectopic placement of nigral 
grafts) is without functional efficacy (Isacson et al., 1986). This theme of circuit reformation is 
elaborated more fully in Section 3, below. 
The subsequent comparison of a wide range of model systems has led to the recognition that there 
is no such thing as THE mechanism of graft action. Rather, grafted neurons and other tissues could 
(and in practice do) influence host structure, neuronal processing and function in a variety of ways. 
In particular, the actual mode of action is clearly dependent upon multiple factors: which host cells 
are affected; the nature of the underlying disease process; whether neurodegeneration is 
progressive or remitting; and the particular behaviours/symptoms that are involved (each of which 
may have quite different neural substrates and demands), alongside which donor cells are 
implanted; where they are placed; and the extent and time course of their integration into the host 
brain. This has led to the formulation of several frameworks for analysis of the diverse mechanisms 
of graft action by both ourselves and others (Björklund et al., 1987, Dunnett & Björklund, 1987, 
1994b, Freed et al., 1985, 1990, Gash, 1987, Buzsaki & Gage, 1988, Gage & Buzsaki, 1989). An 
updated version of the summary table from our own 1994 review (Dunnett & Björklund, 1994b) is 
presented in Table 1. 
Dunnett & Björklund, FNT-IV, chapter 1 page | 5 
 
Insert Table 1 about here 
Non-specific mechanisms 
The manifold and diverse effects of surgical interventions have become better understood in the 
intervening 20 years. Neurosurgical approaches to symptom alleviation in PD, e.g., lesions (Hallett et 
al., 1999) or ‘deep-brain stimulation’ (DBS) (Perlmutter & Mink, 2006) in thalamic and basal ganglia 
circuits, have been particularly informative in this regard. Indeed, DBS has significantly raised the bar 
for developing new stem-cell therapies for PD which must be safer, more reliable, more cost-
effective, and/or more broadly efficacious than the current surgical alternatives. Ultimately, 
however, surgical lesion or stimulation therapies are symptomatic and do not alter the course of the 
underlying disease. Rather, they are providing a much clearer analysis of the ways in which 
complementary circuit blockade, whether by irreversible lesion or reversible depolarisation block, 
can restore a tonic rebalancing of striatal output pathways compensating against the primary cell 
loss. Consequently, a truly reparative cell replacement therapy still has considerable appeal provided 
it can be delivered reliably, safely and cost-effectively.  
A related way in which non-specific effects of surgery may affect functional outcome relates to the 
potential for transplant growth (and in particular overgrowth) to generate ‘space occupying lesions’. 
In 1994 the resulting influence on host function was considered invariably adverse, and indeed the 
potential of residual proliferative cells for metastatic overgrowth continues to be one of the major 
safety concerns for stem-cell derived grafts whatever the CNS target. Nevertheless, the physical 
space occupying effects of graft growth can in some circumstances be beneficial, as exhibited by the 
use of spinal cord tissues to fill and inhibit further enlargement of syrinx formation in traumatic 
spinal cord injury (Falci et al., 1997). 
‘Trophic’ mechanisms 
A second major area of development has been the growing insights into the specificity and targeting 
of trophic mechanisms of recovery. It is almost 120 years since Forssman (Forssman, 1898) coined 
the term ‘neurotopism’ to signify chemical signalling over a distance to attract nerve regeneration 
towards a remote target. These studies were followed by Tello’s (1911) demonstration of successful 
grafting of peripheral nervous tissue into the cerebral cortex with the capacity to stimulate and 
attract regeneration of central nerve fibres, an effect that became well established over the 
following years (Björklund & Stenevi, 1985a). The use of growth-attracting conduits remains a 
central principle of promoting axon regeneration in the injured spinal cord and elsewhere (see 
Section 6 on bridge grafts, below). The importance for cell transplantation was the recognition that 
transplants could potentially be used not only for cell replacement per se, but as an effective vector 
to deliver trophic molecules that are typically too large to cross the blood brain barrier, to precise 
targets in the depths of the nervous system, in order to promote the survival, differentiation and 
growth of endogenous neurones, to protect against traumatic injury or neurodegenerative disease, 
to enhance and modify the function of surviving neurons, and to stimulate and direct axonal 
regeneration and neuronal plasticity via both regenerative and collateral sprouting.  
Initially, neurotrophic mechanisms were postulated as a hypothetical process to account for 
situations where the grafted cells were seen to stimulate sprouting and growth of host fibre 
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pathways. In a number of studies, grafts were shown to promote sustained functional recovery even 
in the absence of graft survival. For example, transplants of adrenal medulla cells – considered for a 
period as an alternative to replace lost dopamine neurons in Parkinson’s disease – were observed to 
yield modest recovery in tests of drug-induced rotation in toxin lesioned animal models, even in the 
absence of survival of the catecholamine-secreting chromaffin cells within the grafts. The most 
compelling interpretation of this conundrum was offered by Martha Bohn and colleagues with the 
demonstration that recovered grafted animals exhibited significant increase in striatal TH-
immunoreactive terminals, interpreted as sprouting of spared dopamine fibres into the more 
denervated areas of the dorsal striatum, consistent with stimulation of endogenous compensatory 
plasticity induced by release of trophic factors from the grafted cells (Bohn et al., 1987).  
With the elaboration over the following decades of multiple new factors with different molecular 
targets and different modes of action, along with developments of gene editing strategies to modify 
grafted cells, a more rational approach to using transplants to promote neuroprotection and 
neuroplasticity has become increasingly popular. In particular, many labs have developed cell lines 
engineered to secrete, often under inducible control, many key trophic molecules, including NGF 
(Ernfors et al., 1989, Strömberg et al., 1990, Cunningham et al., 1991, Dekker et al., 1994, Martinez-
Serrano et al., 1995a, Martinez-Serrano et al., 1995b, Marei et al., 2015), BDNF (Frim et al., 1994, 
Yoshimoto et al., 1995, Alberch et al., 2002), NT3 (Senut et al., 1995, Wang et al., 2014), GDNF 
(Nakao et al., 2000, Espejo et al., 2001, Alberch et al., 2002, Chaturvedi et al., 2003), VEGF (Garcia et 
al., 2014), FGF (Uteza et al., 1999) and other neuroprotective agents such as antioxidants (Barkats et 
al., 1997) and molecules regulating the cell death pathways.  
Moreover, the trophic influence is not only operating from graft to host. The growth, connectivity 
and integration of grafted neurons are themselves modulated by a complex of developmental, 
trophic and tropic influences. So, we can consider combining co-grafts, one to replace lost 
population of neurons, with a second to promote neuronal survival, differentiation, fibre growth and 
targeted connectivity with the host brain (Olson et al., 1990, Liang et al., 2013, Collier & Springer, 
1994, Cunningham et al., 1991, Niijima et al., 1995, Takayama et al., 1995, Deng et al., 2013). It may 
be possible to use such transplants to modulate graft and host neurons via a multiplicity of 
influences. We need to go beyond the original simple distinction between (survival-promoting) 
‘neurotrophism’ and (remote targeting) ‘neurotropism’ (Lu et al., 2001) to distinguish between 
factors which regulate cell survival, differentiation, gene expression and functional activity at the 
level of the cell body, and other factors which modulate sprouting, directional outgrowth and 
guidance at the level of the growth cone of developing and regenerating axons. Such mechanisms 
will contribute importantly to the individual cell’s interactions with its neighbours and its integration 
into the host neuronal network. 
Rather than being considered as a non-specific mechanism, which tended to undervalue the specific 
neuronal replacement strategies of early cell therapy approaches, delivery of neurotrophic factors 
into deep brain targets, at physiological doses, on a sustainable basis, and potentially regulatable by 
molecular switches, is now viewed as an important component of the cell therapy tool box. Indeed, 
many current stem cell-based therapies are focused explicitly on delivering cellular and molecular 
factors that can enhance the survival and health of host brain neurons compromised by aging, 
disease or injury, and/or promote regenerative plasticity for reorganisation in the adult brain.  
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‘Bystander’ effects 
A particular form of the neuroprotective mechanism of functional activity has recently become 
popular, viz. the attribution of graft efficacy to a ‘bystander effect’. This term is applied to situations 
where a graft is seen to exert a functional benefit even in the absence of survival of the grafted cells, 
as for the adrenal medulla studies from an earlier generation, described above. It has become 
particularly popular in the context of mesenchymal stem cell (MSC) grafts and related multipotent 
cell types, often with peripheral administration and putative homing to a dysfunctional target. 
Significant recovery, typically with rapid onset, has been reported in animal models of 
neuroinflammation (Martino & Pluchino, 2006, Einstein et al., 2007), stroke (Bacigaluppi et al., 
2009), demyelination (Uccelli & Mancardi, 2010), brain trauma (Tajiri et al., 2013) and spinal cord 
injury but where long-term survival of the migrating cells cannot be detected. Such observations in 
the CNS are mirrored by the hypothesised mechanisms of MSC cell therapy in other organ systems 
also, such as cardiac repair (Lai et al., 2011). 
To address these effects, a major focus of recent experimental research has been on the potential of 
neural stem/precursor cells to protect the CNS from inflammatory damage. In a major influential 
review, Martino and Pluchino (Martino & Pluchino, 2006) have postulated a basis for the bystander 
effect in the response of neural stem/precursor cells to respond to inflammatory regulators and 
modulate the host inflammatory response. Thus, undifferentiated neural stem cells are responsive 
to a similar wide range of stem cell regulators, inflammatory mediators and growth factors as are 
the cells implicated in inflammatory conditions including experimental allergic encephalomyelitis 
(EAE) and human autoimmune disease, such as multiple sclerosis (MS). The immature grafted 
precursor cells are considered to exert a neuroprotective influence on slowly evolving neurodegen-
erative processes by dissipating host inflammatory reactions, reducing glial scar formation and 
inhibiting apoptotic cell death pathways (Bacigaluppi et al., 2009). 
The optimism surrounding the ‘bystander’ phenomenon with the promise of an effective therapy 
even when the grafted cells do not survive, and the mechanism of action remains unspecified, is in 
danger of encouraging a premature rush to clinical application (Mack, 2011, Doeppner & Hermann, 
2014). However, in a recent review Martino (2016) concludes that “until the basic mechanisms that 
regulate stem cell function are determined, all triumph is misplaced”. In the context of a more 
widespread concern about current trends to unregulated stem cell tourism (Kiatpongsan & Sipp, 
2009), the emphasis of all credible research programs should be not only on well conducted clinical 
research maintaining international trial standards, but also on the detailed basic research to unravel 
the mechanisms of any effects.  
Circuit integration 
Several chapters in the present volume seek to develop functional neural transplantation strategies 
to achieve a variety of disease-specific targets by such relatively diffuse mechanisms of trophic, 
neuroprotective or pharmacological delivery. However, there remain situations where functional 
recovery will require replacement of lost neurons, restoration of damaged connections, and 
reconstruction of complex neuronal circuitry of the host brain, i.e., true ‘brain repair’.  
But to what extent has true brain repair yet been achieved, and if so under what conditions and 
circumstances? The thrust of our earlier reviews (Björklund et al., 1994, 1987, Dunnett, 1995) was 
that the replacement and reconstruction of damaged circuits is indeed necessary for functional 
recovery of cognitive as well as motor function with striatal grafts in the lesioned striatum, and as 
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discussed in further detail in Section 3, below, significant further evidence in support of that view 
has been subsequently acquired (Brasted et al., 1999b, Mazzocchi-Jones et al., 2009).  
Another example in support of this possibility comes from studies of grafted interneurons. Wichterle 
et al. (1999) were the first to show that interneuron precursors derived from the median ganglionic 
eminence (MGE) have a remarkable propensity to migrate and integrate in the brain and spinal cord. 
This has opened up a new line of work using interneuron transplants as a way to modify the 
excitability and function of neural networks, especially in animal models of epilepsy (for review, see 
(Southwell et al., 2014).  
During normal development MGE-derived precursors migrate over long distances to populate wide 
areas of the forebrain, including neocortex, hippocampus and striatum. After transplantation MGE-
derived interneuron precursors are seen to disperse widely within the targeted area, neocortex 
(Wichterle et al., 1999, Alvarez-Dolado et al., 2006, Tanaka et al., 2011), hippocampus (Hunt et al., 
2013, Henderson et al., 2014), striatum (Wichterle et al., 1999, Martinez-Cerdeno et al., 2010), 
amygdala (Hunt et al., 2013) and spinal cord (Braz et al., 2012). The grafted interneuron precursors 
migrate up to 5 mm in neonates (Alvarez-Dolado et al. 2006) and 1.5-2.5 mm in the adult mouse 
brain and spinal cord (Hunt et al., 2013, Braz et al., 2012), differentiate into fully mature GABA-ergic 
neurons, and become both functionally and structurally connected with the neuronal elements of 
the host. They are highly efficient in normalizing neuronal hyperexcitability, e.g., in animal models of 
epilepsy (Baraban et al., 2009, Hunt et al., 2013, Henderson et al., 2014) and neuropathic pain (Braz 
et al., 2012), thus providing some of the best examples of functional integration of new neurons into 
host circuitry.  
For further discussion of this interesting approach, see Chapter 16, this volume, by Spatazza and 
Alvarez-Buylla, and Chapter 17, by Braz, Basbaum and colleagues. In the rest of this chapter we focus 
on transplant-induced restoration of neural circuitry in the CNS regions where the most interesting 
research has been performed along these lines: basal ganglia, cortex, hippocampus and spinal cord. 
3. TRANSPLANT-INDUCED FUNCTIONAL RECOVERY IN STRIATAL SYSTEMS  
Integration of grafted neurons into basal ganglia circuitry  
As indicated above, transplants of striatal precursor neurons derived from dissection of the 
embryonic ganglionic eminence into the striatal lesion model of HD provides perhaps the clearest 
demonstration of the requirements for circuit repair underlying functional recovery currently 
available – as illustrated in Figure 1C and reviewed previously (Dunnett, 1995, 2006, Dunnett et al., 
2000).  
The first support for this hypothesis was provided by the demonstration of functional recovery in a 
series of experiments involving bilateral transplantation of whole ganglionic eminence (WGE)-
derived tissue cell suspensions into neostriatum of rats that had previously received bilateral striatal 
lesions made with the axon sparing excitotoxin ibotenic acid. These grafts were seen to provide 
extensive neuronal replacement of new striatal like structures in the lesioned area, that stained for a 
variety of neurochemical and receptor markers of normal striatum, and contained large numbers of 
neurons exhibiting both the predominant morphology of DARPP-32 positive medium spiny 
GABAergic projection neurons (Graybiel et al., 1989, Wictorin et al., 1989b) and smaller numbers of 
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neurons with the morphological features of all six major striatal cell types (Helm et al., 1990, Clarke 
et al., 1994).  
More detailed analysis indicated a distinct patchy organisation of the graft tissue, reflecting the re-
aggregation with the grafts into distinct compartments comprising striatal like tissues of all neuronal 
types (the patch or ‘P-zones’) interspersed by non-striatal cell populations (the NP zones) that are 
negative for striatal markers but comprise neurons with cortical- and pallidal-like phenotypes 
(Graybiel et al., 1989, Wictorin et al., 1989b). Since the WGE from which the grafts are dissected 
comprise precursors of all ventral forebrain areas including cortical, pallidal and striatal neurons, the 
admixture is not surprising. More notable is that the fact that the cells grafted as a dissociated cell 
suspension self-organise into separate striatal and non-striatal like compartments, and that the 
normal striatal host afferents from cortex, thalamus, nigra and raphé that are spared by the 
excitotoxic lesions, grow and reconnect preferentially with grafted neurons within the striatal 
compartment (Wictorin et al., 1989b, Liu et al., 1990, Labandeira-García et al., 1991, Labandeira-
García & Guerra, 1994). 
Such grafts are functional in that they appear to have the capacity to alleviate deficits of the host 
animals not just in simple motor tests such as lesion-induced hyperactivity or rotation in bilateral 
and unilateral lesioned animals, respectively, but also in a variety of maze learning tasks such as T 
maze position learning, delayed alternation, water maze and radial maze working memory (Isacson 
et al., 1986, Aihara et al., 1994, Deckel et al., 1986, Koide et al., 1993). Such tests involve the 
selection of appropriate choices in both spatial and temporal domains which are known to require 
implementation of motor outputs under prefrontal cortical ‘executive control’, and are dependent 
upon the integrity of cortico-striatal circuits for their proper execution (Rosvold & Szwarcbart, 1964). 
Deficits in such tasks can be induced by either lesions or disconnection at any level in the thalamo-
cortico-striato-pallidal circuit (Divac, 1972, Divac et al., 1967, 1978) and cannot be alleviated by 
pharmacological means or output stimulation/block. Thus, the hypothesis that the grafts were 
working by restoration of a damaged or disconnected circuit within the host brain was compelling. 
However direct exclusion of less specific alternative mechanisms of action is logically difficult and 
the acquisition of direct rather than corroborative evidence has proved challenging. Nevertheless, 
considerable such evidence has now been accumulated from diverse sources. 
Striatal circuit reconstruction 
First and foremost has been the now extensive anatomical evidence of circuit reconstruction. The 
first tracing studies using WGA-HRP crystals deposited with striatal grafts demonstrated retrograde 
tracing in adjacent spared areas of host striatum, the ipsilateral thalamus and substantia nigra and 
weak staining in the host neocortex, with the nigral afferents confirmed by fluorescence 
histochemistry as ramification of dopaminergic fibre terminals within patch zones within the grafts 
(Pritzel et al., 1986). A far more extensive series of afferent and efferent tracing studies was then 
undertaken in a series of interconnected studies performed by Klas Wictorin in the Lund laboratory. 
In the first study he used a combination of WGA-HRP and fluorescent tracers to map subcortical 
afferents from host substantia nigra, thalamus, raphé and amygdala, all of which constitute normal 
sources of striatal input (Wictorin et al., 1988). The second study used PhAL and Fluoro-Gold as 
anterograde and retrograde tracers to map innervation and rich terminal plexus ramification of 
cortical afferents into the grafts, with the same pattern of regional and laminar distribution in 
frontoparietal cortex to that seen in retrograde labelling of normal cortical striatal inputs (Wictorin 
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& Björklund, 1989). And in a third approach Wictorin and colleagues (Wictorin et al., 1989b, 1989c) 
used a combination of anterograde and retrograde tracers to demonstrate clear and reproducible 
efferent projections from grafted neurons to host globus pallidus, endopeduncular nucleus and 
substantia nigra pars reticulata, i.e., the principal targets of the normal striatal MSN projection 
neurons.  
The extent of the capacity of WGE striatal grafts for rich fibre outgrowth to appropriate targets in 
the rat brain was further illustrated in two xenograft studies involving implantation of either mouse 
or human embryonic WGE tissues into the lesioned striatum of immunosuppressed rat hosts 
(Wictorin et al., 1990a). This approach allowed all graft derived fibres to be visualised using antibody 
staining against a mouse-specific neuronal marker, (M6, Wictorin et al., 1991; Labandeira-Garcia et 
al., 1991), or staining using a human specific neurofilament antibody (Wictorin et al., 1990b), and 
confirmed not only the richness of axon outgrowth from the grafts but the selectivity of the 
direction of outgrowth along normal fibre tracts to appropriate targets from the outset, refuting the 
equally plausible mechanism of random outgrowth in all directions followed by pruning of fibres that 
did not establish appropriate terminal connections.  
It is important to note that grafts not only establish appropriate inputs and outputs with the host 
brain, but that the host afferents connect with host neurons at the ultrastructural level, making 
morphologically appropriate synaptic connections with the appropriate neuronal targets within the 
grafts (Clarke et al., 1988, Wictorin et al., 1989a). Clarke & Dunnett (1993) combined anterograde 
degeneration from cortical lesions and retrograde tracing from globus pallidus with Golgi, GAD and 
TH staining at the ultrastructural level to demonstrate that degenerating host cortical axon terminals 
made morphologically appropriate symmetric synapses onto the heads of spines on MSN-like 
neurons within the grafts. Moreover, TH-positive host dopamine axons were seen to make 
asymmetric synaptic contacts onto the necks of spines of the same MSN-like neurons. These 
medium spiny neurons were shown to be GABAergic (by GAD-ir), and project to the host globus 
pallidus (by retrograde WGA-HRP labelling). In combination with a previous study, showing that the 
grafted striatal neurons can grow along the myelinated fibre bundles of the internal capsule to 
reinstate a normal synaptic input to the previously denervated neurons in the host globus pallidus 
(Wictorin et al., 1990b), these connectivity studies provide compelling evidence that the striatal 
projection neurons grafted into the excitotoxin-lesioned striatum become fully integrated into the 
(previously lesioned) host basal ganglia circuitry. Although not fully approaching the density of 
connectivity of the normal striatum, all the components necessary to restore a full cortico-striatal-
pallidal circuitry has been demonstrated. The extent to which this can be achieved in other parts of 
the central nervous system remains to be explored, but the fundamental possibility of true circuit 
reconstruction by implanted young neurons or neuroblasts does appear plausible. 
Functional striatal circuit repair 
The second level of analysis on functional relevance of such anatomical circuit repair was first 
addressed using electrophysiological and in vivo neurochemical monitoring. It was rapidly 
demonstrated by electrophysiological recordings grafted neurons exhibited appropriate patterns of 
low levels of spontaneous activity and responsiveness to dopaminergic modulation (Nishino et al., 
1992, Walsh et al., 1988, Xu et al., 1991, Chen et al., 2002), although the detailed membrane 
properties did not always fully mimic those recorded from intact MSNs (Xu et al., 1991). Combined 
stimulation and recording in brain tissue slices has confirmed bidirectional transmission of action 
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potentials and efficient synaptic communication to the post-synaptic neurons, from host cortex and 
thalamus onto graft MSNs and from the grafts onto host pallidal targets (Rutherford et al., 1987, Xu 
et al., 1991, Nakao et al., 1999).  
The establishment of functional host-to-graft connectivity is further supported by studies using c-Fos 
expression as a cellular marker of stimulation-induced functional activity in the grafted neurons. 
Using this approach Mandel et al. (1992) showed that c-Fos is markedly activated in the grafted 
neurons in response to amphetamine, and that this activation occurred in clusters of cells located 
mainly within the DARPP-32-positive areas within the transplants, i.e., within the striatum-like graft 
compartment which is preferentially innervated by the host dopamine afferents. In a second study, 
Labandeira-Garcia and Guerra (1994) studied the induction of Fos protein in grafted striatal neurons 
following electrical stimulation of the host frontoparietal cortex. Double Fos and DARPP-32 
immunohistochemistry revealed that the Fos-immunoreactive nuclei were concentrated in the 
DARPP-32-positive (i.e., striatum-like) patches, which contained approximately 60% of the density of 
Fos-positive nuclei in the normal striatum, indicating that host corticostriatal fibres not only form an 
axonal network within the graft but also induce postsynaptic responses which may contribute to the 
observed graft-induced amelioration of lesion-derived behavioural deficits. 
In parallel, in vivo dynamic neurochemistry has been used to demonstrate restitution of GABA 
release both in the neostriatum itself (Campbell et al., 1993), and in pallidal and nigral targets 
(Sirinathsinghji et al., 1988, Aihara et al., 1994), suggesting functional inhibitory neurotransmitter 
signalling. Moreover, local regulatory feedback by grafted interneurons is suggested by the 
restitution of cholecystokinin-induced inhibition of striatal dopamine release, indicating grafted MSN 
feedback regulation of dopamine release from nigrostriatal afferents (Sirinathsinghji et al., 1993). So 
again, even if far from fully normal quantitatively, electrophysiological and neurochemical studies 
suggest the graft-derived reconstruction of a functional neuronal circuit capable of restoring 
neuronal signalling necessary to mediate functional information processing and communication 
within the host brain networks.  
Behavioural evidence for transplant-induced circuitry repair  
Further behavioural evidence of recovery linked to circuitry repair has been obtained in more 
complex and better controlled operant tasks involving various discriminative learning paradigms, 
which has allowed us to probe the locus of changes. Operant analyses have followed two basic 
paradigms. The first of these is the use of two retractable lever operant chambers (the ‘Skinner’ box) 
to train animals on a conventional delayed alternation rule with the additional feature of introducing 
variable delay intervals between trials (Dunnett et al., 1999). In addition to the conventional 
measure of the ability of the animal to learn and execute the delayed alternation rule on each 
successive trial, the variable delays allow an evaluation of the rate of forgetting between 
consecutive trials and thereby to monitor any disruption of short term (‘working’) memory. Initial 
studies in lesioned animals indicated that lesions in the medial prefrontal cortex, medial striatum or 
disconnection of the corticostriatal tract bilaterally all serve to disrupt performance on the operant 
delayed alternation task, and that the impairment is due to an ‘executive’ deficit in response 
sequencing required to implement the delayed alternation decision rule (with the striatal lesions 
inducing a characteristic perseverative tendency) rather than to an impairment in remembering the 
response sequence from trial to trial (Dunnett et al., 1999, 2005, White & Dunnett, 2006). Striatal 
grafts alleviate the deficit, restoring the ability of the grafted animals to perform the task, albeit that 
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they require a period of relearning to restore choice accuracy (Dunnett & White, 2006) – an 
important clue to graft function that is elaborated further below. 
The second operant paradigm to have been used extensively has been the choice reaction time task 
in the ‘9 hole box’ operant chamber (Figure 2A), in which rats (or mice) are trained to hold their nose 
in the central hole and then detect and respond to light signals in one of the side holes (Carli et al., 
1985). This task was first introduced by Carli and Robbins to assess the effects of unilateral 6-OHDA 
nigrostriatal lesions and found that unilateral dopamine depletions disrupted animals ability to 
respond to the side contralateral to the lesion, but were fully able to respond accurately on the 
ipsilateral side, whichever was the side of the light stimulus under a series of counterbalanced 
training conditions. Thus the nature of the unilateral dopamine lesion deficit is essentially motor, 
i.e., due to disrupted initiation and execution of a lateralised response in the contralateral side of 
the body, rather than to a sensory deficit or sensorimotor neglect in contralateral space (Carli et al., 
1985).  
We and others have subsequently shown that unilateral striatal lesions are equally associated with 
deficits in response output, rather than contralateral sensory neglect (Brown & Robbins, 1989, 
Brasted et al., 1997). The implantation of striatal grafts had significant capacity to alleviate the 
ability of the rats to respond in contralateral space (Mayer et al., 1992, Döbrössy & Dunnett, 1998, 
Brasted et al., 1999a, 1999b, 1999c, 2000). However, what was most noteworthy in these results 
was not the demonstration of recovery per se, but the observation that when the grafted rats were 
first placed back in the test boxes, even 6 months after transplantation, task performance was as 
impaired as that shown by lesion rats or naïve rats; however, the grafted rats then relearn the task 
rule and improve accuracy of choice performance over a similar 6-8 week time frame as exhibited by 
a naïve rat learning the task for the first time, whereas lesion rats are unable to relearn even with 
very extensive further training (Figure 2B). Thus, it appears that previously trained knowledge of the 
task contingencies is abolished by the lesions (it was fully retained by the control rats even with a 6 
month delay in testing) but can then be relearned de novo in the presence of the graft.  
In the light of a principal function of the striatum being the neural substrate for motor habit and 
stimulus-response learning (White, 1989, Gaffan, 1996, Packard & Knowlton, 2002), these results 
strongly suggest that the grafted striatal neurons have become sufficiently integrated into the host 
neural network to provide an adequate substrate for (re-)learning motor skills and habits. Although 
these observations do not by themselves provide a direct demonstration that the reconstructed 
striatal circuitry is the actual substrate, a transfer-of-training design indicated that the retraining 
must be explicitly on the side involving the transplant circuits, and no amount of training on the 
contralateral side can contribute to the transplant-derived recovery (Brasted et al., 1999b). 
Insert Figure 2. about here 
Striatal circuit plasticity 
Ultimately, behavioural and lesion studies can never provide direct evidence of the neural substrate 
of new learning. However, a particularly informative series of studies have tackled this issue at the 
cellular level using the Calabresi slice model of corticostriatal plasticity. In a long series of studies, 
Calabresi and colleagues have demonstrated long-term synaptic plasticity at the glutamatergic 
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cortico-striatal synapse located on MSN dendritic spines. Directly akin to the standard hippocampal 
LTP model of hippocampal episodic memory introduced by Bliss and Lomo (Bliss & Lømo, 1973, Bliss 
& Collingridge, 1993), having established the stable level of EPSPs in MSNs in response to repeated 
single pulse cortical stimulation, a tetanic burst of cortical stimulation results in long-term change of 
the EPSPs responses in the postsynaptic neuron, which is in the form of depression (LTD) in the 
standard physiological corticostriatal model but is changed into an LTP in a non-physiological low-
magnesium medium (Calabresi et al., 1992).  
Calabresi and his team have provided a detailed molecular analysis of the changes in synaptic 
signalling and pharmacological modulation of corticostriatal plasticity (Gubellini et al., 2004, 
Calabresi et al., 2007). We have used this model system (Figure 2C) to show that LTD is restored at 
the host corticostriatal synapse on grafted MSNs, which exhibits identical physiological magnitude 
and duration as the intact corticostriatal synapse (Figure 2D), the same features under both 
extracellular and intracellular recording conditions, a similar transition to LTP under conditions of 
low Mg2+ (Figure 2E), and the same responsiveness to dopaminergic modulation as seen in the intact 
circuit (Mazzocchi-Jones et al., 2009, 2011). These data provide the first, and perhaps so far only, 
direct evidence that the structural circuits reformed by a striatal grafts exhibit the physiological 
plasticity at the cellular level necessary to provide the substrate for relearning that is consistently 
observed at the behavioural level. Nevertheless, this topic is not static, and it is likely that new 
techniques in optogenetics, rabies virus tracing and DREADDs although not yet applied specifically to 
striatal grafts now provide the tools to yield dramatic new advances in our knowledge on striatal 
circuit communication at molecular and cellular levels than has hitherto been possible with our 
present relatively crude classic recording methods. 
4. TRANSPLANT-INDUCED RECOVERY IN HIPPOCAMPUS AND CORTEX 
DEPRIVED OF THEIR SUBCORTICAL INPUTS 
The ability of intra-striatal dopamine neuron grafts to restore dopamine neurotransmission and 
reverse dopamine-dependent behavioural deficits points to the possibility of using transplants of 
other types of neuromodulatory neurons, such as cholinergic, noradrenergic and serotonergic 
neurons, as a way to restore defective neurotransmission and promote functional recovery in 
dysfunctional forebrain targets, hippocampus in particular. The transmitter-specific histochemical 
methods used in these early brain transplant studies - the Falck-Hillarp histofluorescence method 
and the acetylcholine esterase (AChE) method - performed in the 1970s and 1980s, allowed 
visualization of grafted monoaminergic and cholinergic neurons in their entirety, including the 
totality of their projections in the host brain. In combination with classic anterograde and retrograde 
tracers and behavioural tests, these methods provided powerful tools to study the survival, growth 
and function of these types of neurons after transplantation to the brain and spinal cord.  
Transplantation of septal cholinergic neurons to the deafferented hippocampus 
The hippocampus proved to be a highly useful model to study the capacity of growth and function of 
transplanted neuroblasts. Hippocampus receives a range of regulatory sub-cortical inputs from 
cholinergic, noradrenergic and serotonergic systems, all of which can be removed by transection of 
the fimbria-fornix pathway. In our studies we have used transplants of cholinergic neurons derived 
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from the fetal basal forebrain, noradrenergic neurons from fetal locus coeruleus, and serotonergic 
neurons from the fetal brainstem raphé region, implanted into or adjacent to the hippocampus in 
rats with uni-or bilateral lesions of the fimbria-fornix (Figure 3A,B). The results demonstrated a 
remarkable capacity of grafted cholinergic and monoaminergic neurons to re-establish extensive 
innervation patterns in the dentate gyrus and the hippocampal subfields, which mimicked closely 
those of the normal, intrinsic afferents (Björklund & Stenevi, 1977, Gibbs et al., 1986, Nilsson et al., 
1988b, Leanza et al., 1996) (Figure 3C,E). The grafted cholinergic neurons were shown to restore 
hippocampal acetylcholine release to near-normal levels, as assessed by microdialysis (Nilsson et al., 
1990b), to normalize muscarinic receptor binding (Joyce et al., 1989, Dawson et al., 1989), and to 
form functional synaptic contacts with host target neurons, closely similar to those present in the 
intact hippocampus (Clarke et al., 1986, Segal et al., 1985). 
Insert Figure 3. about here 
Interestingly, the innervation patterns generated by the transplanted neurons differed not only 
between neurons with different transmitter phenotypes, but also between different subtypes of 
cholinergic neurons such that each cholinergic neuron type (from septum, striatum, brainstem or 
spinal cord) was seen to produce distinctly different innervation patterns (Gibbs et al., 1986, Nilsson 
et al., 1988a). The ingrowth and ramification of axons was blocked by the presence of an intact 
cholinergic innervation, and stimulated by removal of the intrinsic afferents, suggesting that axonal 
outgrowth from the grafted neurons is very precisely regulated by the re-innervated target (Lewis & 
Cotman, 1983, Björklund et al., 1979).  
Fimbria-fornix lesions are associated with distinctive patterns of functional deficits in a variety of 
maze learning tasks. The severe behavioural deficits are clearly not due to the loss of cholinergic 
afferents alone. The fimbria-fornix lesion removes not only the septal cholinergic input, but a wide 
range of subcortical afferents, including not only the noradrenergic and serotonergic ones but also 
the GABAergic septal input, which is known to be an important regulator of hippocampal physiology. 
Nevertheless, a broad range of studies performed in both rodents and primates have shown that the 
deficits in hippocampus-dependent learning and memory seen in animals with bilateral lesions of 
the fimbria-fornix can be reversed by transplants of septal cholinergic neurons (Figure 3D), although 
the effect is only partial and also variable between different tests (for review, see (Dunnett, 1991, 
Björklund et al., 1990, Ridley & Baker, 1994, Sinden et al., 1994). Cholinergic reinnervation of the 
previously denervated target seems to be a necessary requirement for recovery to occur (Dunnett et 
al., 1982). This is further supported by the observation that graft-induced recovery in this model is 
correlated with the recovery of high-affinity choline uptake and is blocked by the cholinergic 
antagonist atropine (Nilsson et al., 1987, Li et al., 1992, Tarricone et al., 1991).  
The behavioural recovery seen in these studies is only partial, and may not always occur despite 
good graft-derived cholinergic reinnervation (see, e.g., (Dalrymple-Alford et al., 1988, Cassel et al., 
1990)). This is not surprising given the broad range of subcortical afferents damaged by the fimbria-
fornix lesion. To address this issue, Leanza et al. (1998) performed a study in rats with a more 
selective lesion of the basal forebrain cholinergic neurons, induced by intraventricular injection of 
the 192 IgG-saporin immunotoxin. In these animals, the acquisition of spatial learning in the water 
maze task was completely normalised by cholinergic neuron grafts implanted in hippocampus and 
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frontal cortex (but unaffected by non-cholinergic control grafts). Although the intraventricular 192 
IgG-saporin lesion is not fully specific for forebrain cholinergic neurons (non-specific damage 
includes Purkinje cells in cerebellum and striatal cholinergic interneurons) it is highly efficient in 
removing the cholinergic innervation of both hippocampus and cortex and it spares several of the 
important afferents damaged by the fimbria-fornix lesion, such as the serotonergic and 
noradrenergic systems and the GABAergic septo-hippocampal pathway. The Leanza et al (1998) 
study suggests that the functional recovery induced by cholinergic neuron transplants is more 
prominent when other major subcortical inputs, such as the serotonergic and GABAergic afferents, 
are spared. Indeed, it is known that cholinergic and serotonergic neurons interact, such that 
impairments induced by cholinergic blockade are amplified by lesions (or blockade) of the serotonin 
afferents. Thus, in the water maze task, combined cholinergic and serotonergic lesions induce more 
prominent impairments than lesions of the cholinergic system alone (Nilsson et al., 1988c, Richter-
Levin & Segal, 1989). This is further supported by the finding in the classic fimbria-fornix lesion 
model that combined cholinergic and serotonergic grafts are more effective than grafts of 
cholinergic neurons alone (Nilsson et al., 1990a, Richter-Levin & Segal, 1989). 
Taken together, these data provide substantial evidence that transplants of forebrain cholinergic 
neurons can reinstate functional synaptic transmission in the subcortically denervated hippocampal 
formation, and that the “reafferentation” provided by the grafted neurons is sufficient to restore 
some aspects of hippocampal function lost in animals with lesions of the septo-hippocampal 
pathway. These effects are consistent with the neuromodulatory nature of cholinergic 
neurotransmission, such that the grafted septal neurons may function in a tonic, autoregulatory 
manner, similar to what has been proposed for intrastriatal dopamine neuron grafts, discussed 
above. Studies of graft-derived acetylcholine release, monitored by microdialysis, have provided 
evidence that the grafted neurons are spontaneously active, and that the activity is effectively 
modulated by changes in axonal impulse flow (Nilsson et al., 1990a). In this study we could show 
that acetylcholine release from the graft-derived axonal projection can be boosted – as in the intact 
septo-hippocampal pathway – by gentle sensory stimulation (handling), as well as by electrical 
stimulation of the host lateral habenula, suggesting that intra-hippocampal septal grafts can become 
functionally integrated into host neuronal circuitry, despite their ectopic location. 
Transplantation of basal forebrain cholinergic neurons to the deafferented neocortex 
This “reafferentation” approach has been explored also in animals with excitotoxic lesions of the 
nucleus basalis magnocellularis (NBM). The cholinergic neurons residing in this nucleus provide a 
modulatory innervation of the entire neocortex, the basalo-cortical cholinergic pathway, similar in 
function to the septo-hippocampal pathway discussed above. Excitotoxic lesion of the NBM is an 
effective tool to denervate the neocortex of its cholinergic afferents but, like the fimbria-fornix 
lesion, these lesions are non-specific and involve also non-cholinergic projections neurons located in 
the NBM region, as well as in the adjacent ventral globus pallidus. Thus, the behavioural deficits 
seen in animals with bilateral NBM lesions reflect only in part damage to the basalo-cortical 
cholinergic pathway (Dunnett, 1990, Semba, 2000). Indeed, the impairments observed in rats with 
more selective lesions of the basal forebrain neurons, obtained with the 192 IgG-saporin 
immuntoxin, are more subtle that those seen after excitotoxin (or fimbria-fornix) lesions (Torres et 
al., 1994, Perry et al., 2001, Chudasama et al., 2004). Nevertheless, grafts of cholinergic neurons 
from the fetal forebrain, implanted into the neocortex in rats with excitotoxic lesions of the NBM, 
have been shown to be effective in improving the performance in a number of learning tasks, 
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including passive avoidance, T-maze alternation and radial maze learning (for review, see (Dunnett, 
1990, Dunnett, 1991)). Most likely, the impairments influenced in these tests are associated with 
deficits in selective attention and discrimination of relevant task stimuli, rather than in learning and 
memory per se.  
Overall, the results obtained in these studies support the idea that the grafted cholinergic neurons 
act in a fairly non-specific manner to improve the performance of the subcortically deafferented 
cortex linked to arousal and attention. Similar to the intra-hippocampal grafts, the intra-cortical 
transplants grow to establish a new, extensive AChE-positive innervation in the part of the fronto-
parietal cortex denervated by the NBM lesion. However, it is unclear whether any of the functional 
effects depend on re-establishment of synaptic connectivity. Indeed, studies performed in Rusty 
Gage’s lab (Winkler et al., 1995, Dickinson-Anson et al., 1998), using intra-cortical or intra-
hippocampal grafts of fibroblasts engineered to secrete acetylcholine, have shown that significant 
improvement in performance in the water maze task can be obtained in the absence of any graft-
derived axonal terminal network suggesting that tonic, diffuse activation of cholinergic receptors is 
sufficient to improve cortical function in this model.  
5. ABILITY OF GRAFTED NEURONS TO REGENERATE LONG-DISTANCE AXONAL 
PATHWAYS 
The early studies using either transmitter specific histochemical methods or immunohistochemistry 
using species specific antibodies revealed an impressive capacity of grafted fetal neurons or 
neuroblasts to grow axons over long distances and in a remarkably precise, target-directed manner. 
This has been obtained not only in intact neonatal recipients, but also in adult mice and rats 
subjected to different types of denervating lesions. In adult recipients the outgrowing axons have 
been observed to extend not only within grey matter, but also along white matter tracts. As 
discussed above, such long-distance axon growth has been documented from striatal projection 
neurons grafted to the lesioned striatum (Wictorin et al., 1990b, Wictorin et al., 1991, Isacson & 
Deacon, 1996, Armstrong et al., 2002) and from septal cholinergic neurons grafted to the lesioned 
septum (Leanza et al., 1996). Similar observations have been made in Jeff Macklis´ lab in 
experiments using transplants of mouse cortical neuroblasts, pre-labelled with fluorescent beads 
and lipophilic dyes, and grafted into photolytic lesions of cortical projection neurons in adult mice 
(Hernit-Grant & Macklis, 1996, Fricker-Gates et al., 2002). The most impressive results obtained in 
these early experiments, however, were observed in studies of noradrenergic, serotonergic or 
cortical neurons grafted to the lesioned spinal cord showing extension of axons over several 
centimetres (Nornes et al., 1983, Foster et al., 1985, Li & Raisman, 1993).  
Studies using GFP expressing reporter mice 
The introduction of GFP-expressing reporter mice as a source of tissue for transplantation opened 
new possibilities to visualize and trace axonal projections from grafted neurons with a sensitivity 
and specificity that goes beyond what has been possible with the classic techniques. In our own 
work we have used this approach to trace axons from dopamine neuron transplants grafted to the 
intact or dopamine-depleted substantia nigra in adult mice (Thompson et al., 2009). In this case the 
graft-derived axons, expressing GFP under the tyrosine hydroxylase (TH) promoter, were seen to 
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grow along the nigrostriatal pathway to innervate part of the caudate putamen, and along the 
median forebrain bundle (MFB) to innervate limbic forebrain regions, such as nucleus accumbens, 
olfactory tubercle and amygdala, accompanied by a significant improvement in the amphetamine 
rotation test. Gaillard et al. (Gaillard et al., 2009) have reported similar results using cells with GFP 
expressed under the less specific CBA promoter. 
These studies have revealed a remarkable specificity of axonal outgrowth from the grafted DA 
neuroblasts. The extension of GFP-positive axons from the graft was clearly polarised: The vast 
majority of the axons exited the graft at the rostral pole, oriented rostrally along the intrinsic nigro-
striatal fibre trajectory and the adjacent MFB, and the distribution of terminals in striatal, limbic and 
cortical areas matched closely the projection patters of the intrinsic midbrain dopamine neurons. 
The grafts contained the normal complement of A9 (nigral, Girk2-positive) and A10 (calbindin-
positive) neuronal subtypes, and the retrograde tracing experiment indicates that graft neurons 
projecting to the striatum were of the correct, nigral phenotype. Along the nigro-striatal pathway 
the axons were arranged in a loose non-ramifying bundle, but as they reached the border between 
the globus pallidus and caudate-putamen they were seen to branch profusely, suggesting a direct 
influence of local cues on the ability of the growing axons to establish a new terminal innervation 
network in the denervated target. This was further supported by the observation that the growth 
and extension of the graft-derived GFP-positive fibres were much more restricted in non-lesioned 
hosts where the intrinsic dopamine projections were left intact.  
A second example comes from studies performed in Afsaneh Gaillard’s lab using transplants of GFP-
expressing cortical tissue, obtained from E14 transgenic mice and grafted to a cavity made in the 
sensori-motor cortex of adult wild-type mice (Gaillard et al., 2004, 2007). Again, the results are 
striking: The graft-derived, GFP-expressing axons could be traced over large distances, within white 
matter tracts, not only to the contralateral cortex, but also to a number of sub-cortical targets, 
including striatum, thalamus, pontine nuclei and the cervical spinal cord. The pattern of projections 
was notably similar, albeit less abundant, to that observed in control mice following injection of an 
anterograde tracer (BDA) in the same cortical area, following the same axonal growth trajectories in 
the internal capsule, the cerebral peduncle and the pyramidal tract. Notably, about 30% of the 
graft-derived axons were seen to be myelinated, thus confirming that the ability for long-distance 
axon growth is not limited to neurons with non-myelinated axons. Electron microscopy showed 
GFP-expressing terminals making synaptic contacts with host cortical, striatal and thalamic neurons, 
and host neurons making both axo-somatic and axo-dendritic contacts with GFP-positive neurons in 
the transplant, suggesting that the grafted neurons had, at least in part, become integrated into 
host neural circuitry. 
Tuszynski and collaborators have used cells from a transgenic rat expressing GFP under the 
ubiquitin promoter to trace connectivity from neural progenitors grafted to the lesioned spinal cord 
in adult rats (Lu et al., 2014, Kadoya et al., 2016)see also Chapter 14, this volume). The cells were 
embedded in a growth factor containing fibrin matrix and implanted into a lesion cavity transecting 
the cord at T3. At 7 weeks post-grafting GFP-expressing axons were seen to extend both rostrally 
and caudally over about 25 mm in each direction, some of them running within white matter and 
myelinated by host oligodendrocytes. Further analysis indicated the presence of both glutamatergic 
(vGlut-positive) and GABAergic (GAD65-positive) axons among the outgrowing fibres, and 
immunoelectron microscopy identified synaptic contacts between the graft-derived axon terminals 
and host neurons and dendrites. In the first study, over the 7-week period the grafts had filled the 
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lesion cavity, and host axons originating in the brain stem (serotonin-expressing, or labelled with 
BDA injected into the brain stem reticular formation) were seen to extend into, but not beyond the 
graft (Lu et al., 2014), whereas in a subsequent study host axons were confirmed to extend up to 
mm into the distal segments of the spinal cord (Kadoya et al., 2016). Recovery of hindlimb 
movements was observed 4-6 weeks after grafting. Re-transection of the cord just rostral to the 
graft resulted in a complete loss of the recovered function when measured 1 week later. Electrical 
stimulation above the lesion were seen to generate evoked responses three segments below the 
graft site, but with prolonged latency, consistent with the hypothesis that the transplant had 
established functional connectivity across the lesion, via a synaptic relay through the graft. 
Studies using cells derived from embryonic stem cells 
The studies discussed above provide compelling evidence that the adult CNS retains the capacity to 
guide immature, growing axons over large distances and in a target-specific manner. Conversely, it 
seems clear that neuroblasts or young post-mitotic neurons that are programmed to establish long-
distance connections with defined targets during normal development, are able to express this 
property also in the lesioned adult CNS. This regenerative capacity of grafted neuroblasts points to 
interesting therapeutic possibilities, and raises the question whether neurons derived from stem cells 
– embryonic stem cells (ESCs) and induced pluripotent stem cells (iPSCs), in particular – can be made 
to express the same capacity for pathway reconstruction. Studies performed during the last decade 
suggest that this may indeed be the case.  
Early attempts to generate transplantable neurons from mouse or human ESCs were hampered 
either by poor overall survival or by inclusion of proliferative cells that generated expanding 
tumours at the graft site. Thanks to the more refined cell derivation protocols developed over the 
last few years these problems are now largely solved, and open up the prospect for interesting 
studies of ESC- and iPSC-derived cells implanted in diverse brain regions, such as cortex, striatum, 
substantia nigra and the damaged spinal cord. These new protocols build on knowledge derived 
from the study of normal brain development, taking advantage of insights into how morphogens, 
such as RA, SHH, BMP, fibroblast growth factors (FGFs) and WNTs, act to generate neuronal 
diversity in the CNS during embryonic development. 
Particularly interesting results have been obtained in studies using ESC-derived cortical neurons. A 
number of recent studies have generated transplantable cortical progenitors from mouse (Gaspard 
et al. 2008, Idegushi et al. 2010, Michelsen et al. 2015) or human pluripotent stem cells (Denham et 
al., 2012, Espuny-Camacho et al., 2013, Steinbeck et al., 2012). In neonatal mice or rats, the ESC-
derived, GFP-labelled cells have been shown to survive well after transplantation to the neocortex. 
Some of them develop into mature pyramidal-like neurons with the capacity to extend axons along 
major corticofugal pathways, including the corpus callosum, the external and internal capsules and 
the cerebral peduncles. The GFP-positive graft derived innervations are consistent with pyramidal 
neurons of diverse layer identities: layer IV-type neurons innervating thalamus, layer V-type 
neurons innervating striatum and brainstem, and layer II-V-type neurons innervating ipsi-and 
contralateral cortex.  
In the Espuny-Camacho et al. (2013) study, performed in neonatal immunodeficient NOD-SCID mice, 
the sub-layer specificity of the projection patterns was supported by retrograde tracing, showing 
that many of the human pyramidal-like neurons labelled from thalamus expressed the layer IV-
marker TBR1, and that the neurons labelled from the superior colliculus expressed the layer V-
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marker CTIP2. Interestingly, Gaspard et al. (2008) have shown that the laminar commitment of the 
neurons depends on the duration of time in culture: the ones generated first (at 12 days of culture) 
project primarily to thalamus (consistent with deep-layer neurons) and those generated later (at 14-
17 days of culture) project more prominently to cortex (consistent with neurons in more superficial 
layers).  
More recently, Michelsen et al. (2015) have extended this work to adult mice with excitotoxic 
lesions of visual or motor cortex. The results show that the regional specification of the grafted 
neurons is important for establishing specific patterns of connectivity. Extension of axons along the 
occipital cortical pathways, from grafts placed in the visual cortex, could be achieved when 
transplanting ESC-derived progenitors with molecular signatures of occipital cortex but not after 
transplantation of cells with signatures of motor cortex. These findings suggest that the ESC-derived 
cortical progenitors possess intrinsically specified programs for the establishment of target-directed 
connectivity. Interestingly, the grafted occipital cortical neurons, but not those derived from motor 
cortex, were shown to respond to visual stimuli, similar to the nearby cortical neurons in host visual 
cortex, suggesting that the grafted neurons become functionally integrated in a manner 
characteristic for each pyramidal neuron subtype. Overall, the capacity for the establishment of 
long-distance, targeted connectivity of ESC-derived cortical neurons appears quite similar to that 
obtained with fetal cortical tissue transplanted to the cortex in neonates or lesioned adult hosts 
(Gaillard & Roger, 2000, Gaillard et al., 2007). 
In our own work we have focused on the possibility to generate transplantable dopamine and 
striatal neurons from ESCs or iPSCs. Early experiments along these lines were successful in 
generation of TH-positive neurons from mouse and human ESCs and iPSCs, but the limited capacity 
of these cells to re-innervate appropriate denervated targets in the host brain suggested that most 
of the cells were incompletely specified and not of the appropriate midbrain phenotype. During 
embryonic development midbrain dopamine neurons are derived from floorplate cells, determined 
by timed interaction between SHH, FGF and WNT signaling (Bonilla et al., 2008, Ono et al., 2007). 
Based on these insights a new generation of protocols have been developed to derive midbrain 
floorplate-like cells from human ESCs and iPSCs, (Kirkeby et al., 2012, Kriks et al., 2011, Sundberg et 
al., 2013). These cells – characterised by their expression of two key transcription factors, FoxA2 
and Lmx1A – survive transplantation and develop into fully mature TH-positive neurons without any 
signs of overgrowth or tumour formation. Importantly, the vast majority of these neurons express 
phenotypic markers characteristic of the two major midbrain dopamine neuron subtypes, the A9 
neurons residing in the substantia nigra, and the A10 neurons located in the ventral tegmental area 
(Björklund & Dunnett, 2007).  
In adult 6-OHDA lesioned rats the TH-positive neurons generated by these protocols are highly 
efficient in re-innervating both A9 and A10 targets after transplantation, either into the striatum 
(Kirkeby et al., 2012, Kriks et al., 2011, Sundberg et al., 2013) or into the substantia nigra (Grealish 
et al., 2014). In the Grealish et al. (2014) study, the performance of the hESC-derived dopamine 
neuron precursors was compared with that of fetal human ventral midbrain (VM) dopamine 
neurons, obtained from 5.5 - 8 week old fetuses. The cells were transplanted unilaterally into the 
lesioned substantia nigra and axonal outgrowth was studied using antibodies directed against 
human NCAM and TH. Graft-derived axons could be traced in large numbers along the medial 
forebrain bundle and the nigrostriatal pathway to provide innervations in appropriate A9 and A10 
targets, including striatum, nucleus accumbens, amygdala, olfactory tubercle and infra-limbic and 
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cingulate cortex, reaching about 10 mm from the graft deposit. The axonal outgrowth was notably 
similar for both types of graft, and the functional potency – assessed as the minimal number of TH-
positive neurons necessary to induce a measurable functional effect – was similar for both cell 
preparations. Moreover, fibre density measurements showed that fetal and hESC-derived neurons 
had a similar propensity to innervate A9 and A10 targets, although the A9-specific innervation in the 
dorsolateral striatum was overall of higher density in rats with fetal VM grafts.  
The functionality of the ESC-derived dopamine neurons is further supported by a study from Lorenz 
Studer´s lab using optogenetics to modulate the activity of the grafted cells (Steinbeck et al., 2015). 
In this experiment, human ESC-derived dopamine neurons expressing the inhibitory, light-sensitive 
halo-rhodopsin chloride pump were transplanted to the striatum in immunodeficient, 6-OHDA 
lesioned mice. In the grafted mice, optogenetic silencing of the graft neurons was observed to 
reverse the recovered motor function to the level of the non-transplanted lesion controls. Further 
electrophysiological recording (in slices) showed that the graft-derived innervation exerted a 
modulatory action on glutamatergic synaptic transmission onto medium spiny striatal neurons, 
similar to that of the endogenous dopamine innervation, consistent with re-establishment of 
functional synaptic transmission. 
The hESC-derived dopamine neurons generated in these protocols hold great promise for use in 
clinical trials: their properties are closely similar to the authentic dopamine neurons derived from 
human fetal VM, they can be generated in large numbers, and they survive and function just as well 
as fetal-derived VM neurons after transplantation without any signs of overgrowth or tumour 
formation. The ongoing efforts to explore their use in PD patients are discussed by Kirkeby et al., 
Studer et al. and Takahashi et al. in Chapter 7, 8 and 9.  
6. USE OF NEURAL TRANSPLANTS TO BRIDGE TRANSECTING LESIONS IN 
BRAIN AND SPINAL CORD. 
The idea for using neural tissue transplants to act as bridges to allow circuit repair arose out of 
studies on the more fundamental basic question of why do peripheral axons and pathways 
regenerate so much more effectively in the peripheral than in the central nervous system. The 
classic anatomical studies on nerve regeneration by Cajal and others (Cajal, 1928) described in 
exquisite detail the sprouting response, formation of new growth cones, and axon regeneration of 
axotomised DRG sensory and spinal motor axons along peripheral nerve paths to peripheral targets, 
and the slow restitution of peripheral sensory and motor function in time. By contrast, in the adult 
mammalian CNS, a similar initial sprouting is followed by abortive regeneration and dying back of 
the proximal axon (Cajal, 1928). The observation that regenerating dorsal root ganglia axons can 
grow long distances distally back to peripheral targets, but that proximal regeneration in the dorsal 
nerve root stops abruptly at the dorsal root entry zone transition between peripheral and central 
glia indicates clearly that the CNS / PNS discontinuity relates principally to the glial environment 
rather than to the regenerative capacity of central vs. peripheral neurons per se (Carlstedt et al., 
1989).  
Detailed analysis over three decades has highlighted a number of important differences between the 
central and peripheral growth environments, including the presence of different trophic and 
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inhibitory factors; different glial populations providing different scarring responses; and expression 
of different basal lamina and surface adhesion molecules as substrates for stimulation, guidance and 
structural support of regenerating axons (Fawcett et al., 2001, Chew et al., 2012). Critically, in vitro 
co-cultures reveal that the principal peripheral myelinating glia, the Schwann cell, provides a far 
more effective substrate for neurite growth from both central and peripheral neurons than do the 
equivalent central glia, the oligodendrocyte (Bunge et al., 1988, Schwab & Caroni, 1988). As noted in 
Section 2 above, it is more than a century since Tello first asked whether a graft of peripheral nerve 
might promote regeneration of motor axons to their peripheral targets (Tello, 1911). So, it was 
natural to ask whether similar grafts of sections of peripheral nerve, or preparations of their 
predominant Schwann cell glia might allow similar regeneration of central axons?  
Pioneering experiments by Albert Aguayo and his team in Montreal, demonstrated this possibility, 
and opened the way for promoting long distance axon growth in the CNS, as in the PNS. An initial 
approach to spinal cord injury was to insert, in rats, a piece of seural nerve into the cavity formed by 
complete transection of the mid-thoracic spinal cord (see Figure 4A). HRP injections into the 
proximal or distal cord stumps revealed effective labelling of host neurons on the other side of the 
transection, indicating regrowth of the central axons through the peripheral bridge (Richardson et 
al., 1980, Richardson et al., 1982). An alternative approach, which has attracted particular attention 
was undertaken by David and Aguayo (1981). They implanted a 35mm long segment of peripheral 
nerve extra-spinally in the subcutaneous tissues along the back, so as to provide a bridge with the 
proximal end inserted into the medulla and the distal end at a mid thoracic level (Figure 4B). At post 
mortem 6 months later, the peripheral nerve grafts were then cut within the extraspinal zone and 
HRP crystals applied to the cut ends to trace host axons projecting into and through the grafts. Many 
retrogradely-labelled host neurons were observed within both the medulla and distal spinal cord, 
typically over a 4-6.5mm band close to the site of nerve root insertion. Moreover, anterograde 
labelling of host axons was also observed extending from the nerves in both medulla and distal 
spinal cord, but typically extending no more than 2mm into the host neuropil (David & Aguayo, 
1981). Thus adult central neurons can regenerate long distances through a peripheral nerve grafts 
(in both ascending and descending directions), but the regenerating axons failed to show any 
comparable long-distance axon growth once they re-enter the adult host spinal cord environment. 
Thus a key challenge for effective spinal cord regeneration will be not only how to deliver long 
distance growth of regenerating or replaced neurons to innervate distal targets, but also how to 
promote appropriate reinnervation and effective long-distance extension of the regenerating axons, 
at least within large or extended target zones. 
Insert Figure 4 about here 
The use of the principle axon-ensheathing and myelinating glial cells of the PNS, the Schwann cell, to 
promote central regeneration in spinal cord injury has been an active and productive topic of 
investigation over the last 30 years, a project pioneered by Richard and Mary Bunge and their 
colleagues at the Miami Centre. Their programme has focussed on isolating Schwann cells and to 
refine preparation methods to achieve scaring free integration with the host spinal cord in partial 
and complete transection models (Figure 4A), and to deliver the most effective substrates for axon 
regeneration (Bunge & Wood, 2012). In chapter 18, Mary Bunge and colleagues provide a recent 
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update of the origins and recent refinements of the cell preparation protocols, the comparison of 
the capacity for regenerative support provided by human vs rat Schwann cells, and the development 
of a translational pathway towards clinical application. Following a similar theme, a number of 
laboratories are now seeking to generate an equivalent Schwann cell-like cell for human 
transplantation from stem cell starting materials (Dulin & Lu, 2014) and in chapter 14 Paul Lu 
discusses the first attempt to deliver stem cell-derived glial transplants to clinical application in 
spinal cord injury.  
A fourth alternative strategy to bridging spinal cord injury is found in the work of Raisman and 
colleagues aimed to identify an alternative source of readily accessible regeneration-promoting glial 
cells. Li, Field and Raisman found that transplants of olfactory ensheathing cells (OECs) cultured from 
rat olfactory bulb placed into small lesion cavities in the spinal cord could effectively bridge the 
lesions, promoting efficient regeneration of central axons through the graft (Li et al., 1997, Li et al., 
1998). The interesting feature of this population of glial cells is that they can potentially be 
harvested via a trans-nasal route from a living human adult donor for use in allotransplantation (Li et 
al., 1997, Raisman, 2001). In experimental animals, a systematic series of studies have subsequently 
evaluated the functional efficacy of such grafts in tests of forelimb motor reaching (Li et al., 1997, 
Keyvan-Fouladi et al., 2003), breathing and climbing (Li et al., 2003). These studies have led on to an 
initial clinical trial in which autologous OECs from a nasal mucosa biopsy have been transplanted into 
the spinal cord cavity in 6 patients with chronic mid thoracic paraplegia. The initial results show that 
this approach is feasible and safe, with some imaging evidence of white matter fibre tract regrowth, 
and some sparse functional recovery at 1 year (Tabakow et al., 2013).  
In parallel, Ibrahim et al (2014) have explored the use of OECs derived from the olfactory bulb itself, 
rather than from the olfactory mucosa, using a keyhole surgical approaches to source the cells from 
the transplant recipient themselves (Czyz et al., 2014, 2015). Results in a first patient transplanted 
with autologous olfactory bulb cells are looking particularly promising in reporting detectable 
recovery of voluntary movements and partial recovery of sensation in the lower limbs. Interestingly, 
transplantation in this patient was accompanied by intensive and extended pre- and post-operative 
rehabilitation (see chapter 13 by Clinch, Busse and colleagues).  
Nevertheless, although these positive observations are accompanied by indications of reformation 
of white matter connectivity, as assessed by MR imaging, the mechanisms by which any functional 
changes are achieved remain uncertain (Keyvan-Fouladi et al., 2002). Thus, OECs may contribute a 
bridging substrate for host axon regeneration, and also contribute to peripheral-type remyelination 
and a broad range of trophic influences. Moreover, recovery depends on at least a few host 
corticospinal fibres spared by the lesion as a source of extensive sprouting and synaptic 
reorganisation (Keyvan-Fouladi et al., 2002).  When comparing bulbar and mucosal grafts in a rat 
rhizotomy paradigm, it was noteworthy that both graft types exhibited recovery in paw reaching, 
even though the latter grafts did not survive (Ibrahim et al., 2014). Similarly, in the spinal cord 
transection model rejection of the graft did not abolish the recovered function, although in this 
situation the grafts had survived long enough for host axon bridging to have been established (Li et 
al., 2016). More than anything else, these studies highlight the degree to which the establishment 
and maintenance of functional recovery involves a complex array of interacting mechanisms, such 
than any opportunity for clinical translation depends on the precise selection of the cells, methods 
and timing of surgical intervention and interaction with the host environment. 
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Similar bridging strategies have been used in brain, using glial cells to provide guidance channels for 
promoting regeneration of central axons over long distances or within a central environment that 
would not normally support such endogenous regeneration (from axotomised host neurons) or 
exogenous growth (from transplanted replacement neurons). Thus, for example, we have engaged 
in seeking to promote regeneration of the nigrostriatal pathway. Initial studies of proof of principle 
were undertaken in the standard unilateral 6-OHDA lesion model in which solid VM grafts were 
positioned at midbrain level on the surface of the superior colliculus in combination with a 
peripheral sciatic nerve that bridged the 2-3 cm gap to the denervated host striatum (Figure 4C). 
Post mortem TH immunohistochemistry indicated extensive TH-positive fibre growth from 
dopaminergic neurons with the grafts, throughout the length of the peripheral nerve bridge, to 
sprout and provide local terminal ramification in the host striatum (Aguayo et al., 1984). Such grafts 
were seen to be competent to alleviate amphetamine-induced rotation, albeit over a slower time 
course than achieved with intrastriatal VM graft placement (Aguayo et al., 1984, Gage et al., 1985). 
Importantly behavioural recovery was abolished by making a cut of the peripheral nerve, indicating 
the importance of the bridge-graft mediated reinnervation for its functional efficacy. 
In order to refine the nigrostriatal bridge model we introduced an alternative intracerebral grafting 
strategy, laying down the bridge cells by an oblique injection along a direct track between the 
substantia nigra and the striatum (See Figure 4D; Dunnett et al., 1989). In the first study, the 
combination of intranigral VM grafts with alternative nigrostriatal bridges comprising astrocytes or 
laminin-based substrates were ineffective, and although bridges of striatal (WGE) neurons did 
stimulate axon ingrowth the grafts were full of terminal ramifications with only few axons extending 
as far as the striatum. A far more effective cell source for the bridges, as predicted by the studies in 
spinal cord outlined above, was the use of cultured Schwann cells, in particular when modified to 
express specific trophic factors on which DA neuron survival is dependent, FGF and GDNF. These 
engineered Schwann cell bridges promoted extensive outgrowth of TH positive axons from 
dopamine neurons within the intranigral VM grafts over 10-15mm to the 6-OHDA lesioned striatum 
(Wilby et al., 1999, Brecknell et al., 1996b). In a related study, in which the lesions were made not by 
the toxin 6-OHDA (which kills the nigral neurons), but by a knife cut lesion (which transects the 
axons leaving the nigral neurons themselves largely intact) the oblique Schwann cell bridge was seen 
to stimulate axon regeneration of the endogenous axotomised host nigral cells to enable a more 
extensive reinnervation of the denervated striatum (Brecknell et al., 1996a). 
A final distinction we may draw is the one between “passive” and “active” bridges. In an early review 
of spinal cord transplantation, Barbara Bregman (1994) highlighted how transplants of spinal cord 
tissue into a cord transection cavity can serve both as a ‘bridge’ and as a ‘relay’. The former situation 
was seen most often in immature rats, whereby host axons were seen to grow through the neural 
transplant and back into the distal host cord, much as described above for the peripheral bridges of 
David and Aguayo (David & Aguayo, 1981). Conversely, in adulthood, host axons would innervate a 
spinal cord graft, making potential contacts with the grafted spinal cord neurons, which in turn grew 
back into the distal cord, providing a relay of communication across the site of injury (Bregman et al., 
1993). In support of this idea subsequent studies have confirmed a synaptic basis of the relay (White 
et al., 2010, Bonner et al., 2011).   
The concept of “passive” and “active” bridges have been explored also in the septo-hippocampal 
system. Kromer et al (1981) and Wendt et al. (1983) made use of transplants of either fetal 
hippocampal tissue, or a piece of peripheral nerve, to provide a bridge across a lesion cavity 
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transecting the fimbria-fornix pathway (see Figure 4E,F). AChE-positive cholinergic axons, were seen 
to regenerate in large numbers from the septum into the graft, and some of them extended also 
across the graft-host border into the denervated hippocampus. In a subsequent study, Kawaja et al. 
(1992) showed that the capacity to promote regeneration of the host septo-hippocampal pathway, 
across the lesion and into the host hippocampus, was greatly promoted by grafts of fibroblasts 
engineered to secrete NGF. The alternative approach to create an “active” relay bridge has been 
explored by Nilsson and colleagues in studies of cholinergic and noradrenergic neuron transplants 
(see Figure 4E,F). As described above in Section 4, grafts of embryonic cholinergic or noradrenergic 
neurons implanted into the fimbria-fornix lesion cavity, adjacent to the denervated hippocampus 
provide rich transmitter specific patterns of reinnervation of the target. Using microdialysis, Nilsson 
et al, (1990c) found that acetylcholine release from graft-derived neurons in the hippocampus was 
under precise regulation of the host brain, which was shown by anatomical tracing and 
immunohistochemistry to be due to rich regulatory ingrowth of brainstem, hypothalamic and septal-
diagonal band neurons into the grafts.  
The theme of relay bridging has received renewed attention recently with the investigation of 
alternative stem cell-derived neurons for transplantation in spinal cord injury. Again, there is 
growing evidence that grafts of neurons differentiated to spinal cord-like fates can integrate into the 
site of spinal cord injury with both afferent and efferent connections with the host CNS (Lu et al., 
2012), indicating a functional benefit by relaying ascending as well as descending connections 
through the grafts, to and from the brainstem (Dulin & Lu, 2014). 
It should be noted that, in terms of mechanism, the ‘active’ or ‘relay’ bridges described above, 
establishing afferent and efferent connections within the host brain, are not fundamentally 
dissimilar to the reciprocal graft-host connectivity and integration into the host neural circuitry 
described for striatal grafts as the basis for true ‘brain repair’. To the extent that a distinction can be 
drawn, it relates to the graft being seen as providing a relay of host information across the graft in 
the former case, vs. the graft providing an additional transformation of that information through 
local circuit processing before its relay onwards in the latter case. These alternative modes of action 
are not mutually exclusive, but reflect complex interactions between grafted cells and host tissues 
that need full separate analysis in each particular case. 
7. PROSPECTS FOR TRANSLATION TO CLINICAL APPLICATIONS 
The first report of successful clinical neural transplantation was published over 25 years ago (Lindvall 
et al., 1990), and the previous 3 volumes in this series – 1994, 2000 and 2012 – were all published in 
the context of the clinical realisation of the basic experimental science, and the core principles of 
how grafts work and how to make them work better were already appreciated (Dunnett & 
Björklund, 1994b). Nevertheless, the enthusiastic consideration of a broad range of other disease 
applications discussed in 1994 (Dunnett & Björklund, 1994a), was tempered by slow progress in 
2000 (Dunnett & Björklund, 2000), and the challenges raised by the first failed randomised 
controlled PD trials in the early 2000s (Freed et al., 2001, Olanow et al., 2003) slowed progress still 
further with little in the way of progress toward additional clinical targets achieved by 2012 (Dunnett 
& Björklund, 2012).  
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However, the Zeitgeist has improved considerably in the last 5 years. A number of critical analyses 
have led to a better understanding of the weaknesses in the design of the two failed NIH trials, and 
why even encouraging results were so negatively interpreted (Barker, 2003, Wijeyekoon & Barker, 
2009). In Parkinson’s disease, reanalysis of the preceding data on a multicentre scale has highlighted 
key features of trial design that need to be addressed in order to have a chance of revealing 
significant therapeutic benefit. This includes more careful selection of patients, delivery and 
distribution of cells transplantation, effective immunosuppression, and design of multidimensional 
functional and surrogate outcomes (Piccini et al., 2005, Allan et al., 2010).  
As highlighted in the chapter by Kirkeby et al. in this volume (Chapter 7), this field is now 
reinvigorated by the development of stem cell based alternatives for cell therapy in PD. As reviewed 
in the chapter by Lorenz Studer, his group is one of several teams worldwide to have developed 
effective protocols for differentiating human pluripotent stem cells to midbrain dopamine neurons, 
which are functionally equivalent to authentic embryonic dopamine cells according to multiple 
behavioural, physiological and molecular criteria (Kriks et al., 2011, Pfisterer et al., 2011, Kirkeby et 
al., 2012).  As reviewed in Section 2, these cells function appropriately in the relevant animal 
models, , and the ‘NYSTEM’ programme led by Lorenz Studer in New York is now well advanced 
towards the first-in-man clinical trial in PD patients. Parallel programmes are already following on – 
including ‘Stem-PD’ coordinated by Roger Barker in Europe; and the CiRA trial coordinated by Jun 
Takahashi in Kyoto, Japan, based on an alternative cell source, i.e., DA neurons differentiated from 
human iPS cells. These initiatives are discussed further in Chapter 7, 8 and 9 in this volume. 
Encouragingly, and in contrast to previous competitiveness, the new PSC-derived cell therapy era is 
marked by a remarkable degree of cooperation through the newly-formed ‘Gforce-PD’ network, to 
address common standards of regulation, experimental design and sharing of reagents, tools and 
assessment protocols, so that even if cell sources and transplant methods may differ the trial 
outcomes will be comparable according to common standards and measures (Barker et al., 2015). 
As in PD, so also in HD. Following initial reports of positive outcomes in individual cases from at least 
4 centres (Bachoud-Lévi et al., 2000, Reuter et al., 2008, Paganini et al., 2014, Hauser et al., 2002), 
and follow up of benefit lasting at least 6 years (Bachoud-Levi et al., 2006), scale up to larger trials 
has been slower to realise. The logistic difficulties based on sourcing adequate supplies of fetal 
tissues of suitable quality and standardisation has been challenging, and the one large multicentre 
French cohort, started in 2003 is still to complete and report. Again, the rapid advances in stem cell 
science have led to recent publications of reliable protocols for differentiating both MSN projection 
neurons and striatal interneurons from both hES and hiPS cell sources (Evans et al., 2012, Precious & 
Rosser, 2012, Arber et al., 2015). These cells survive transplantation, integrate into the host brain 
with the grafts expressing both DARPP32-positive MSN and interneuronal phenotypes (Shin et al., 
2012, Delli Carri et al., 2013, Arber et al., 2015). Although, to date, at best modest functional benefit 
has been reported following stem cell grafting in the quinolinic acid lesion model (Delli Carri et al., 
2013), the conditions for effective cell transplantation in HD are increasingly well understood 
(Freeman et al., 2011, Rosser et al., 2011), and a major multicentre collaborative effort, ‘Repair-HD’, 
is underway to develop striatal projection and interneuronal derivation towards a first-in man 
clinical trial (Dascher-Nadel et al., 2014). 
The flexibility, availability and potentials for standardisation and quality control offered by stem cell 
derivation of transplantable neuronal populations, exemplified above for PD and HD, is opening the 
way for the first time for applications in a much broader range of clinical indications. While 
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recognising the worrying proliferation of ‘stem cell tourism’ clinics offering entirely unproven (albeit, 
expensive and highly profitable) cell therapies around the world, the majority of which are entirely 
spurious (Kiatpongsan & Sipp, 2009, Daley et al., 2016), there is nevertheless a parallel rapid growth 
in credible science (which this volume seeks to capture) seeking to lay the experimental foundations 
for more science-driven applications based on defined protocols for differentiation of specific cell 
types for each clinical application.  
So how can a credible therapy be distinguished from a spurious one? Recent guidelines provided by 
the ISSCR (Daley et al., 2007, Daley et al., 2016) are important but can be difficult to apply in an 
individual situation without inside knowledge and expertise. As outlined in Section 5 above, a key 
consideration must be to provide an understanding of the mechanism by which the stem cell 
therapy is expected to yield functional benefit. Moreover pre-clinical validation must include clear 
experimental evidence that the transplantation intervention works in an appropriate model of 
disease, and that it does so by the hypothesised mechanism(s). In a review for the EuroStemCell 
consortium, Roger Barker (2013) considers that a potential new stem cell therapy should meet four 
criteria: 
 “(the) stem cells can make authentic replacement neurons of the type you want (nigral 
dopamine cells with PD; striatal DDARP-32 projection striatal neurons in Huntington’s 
Disease etc); 
 the properties of these stem-cell derived neurons can be reproducibly demonstrated in the 
laboratory (and ideally more than just one laboratory), both in the dish and in animal models 
of disease; 
 the neurons can survive long term in animal models of disease and have functional benefits 
to that animal; and 
 all of this can be done without evidence of cell overgrowth or transformation into malignant 
(cancerous) cells within the transplant.” 
We now see a wide range of new applications under active investigation, including the development 
of stem cell derived neurons for stroke, multiple sclerosis, epilepsy, ALS/motor neuron disease, 
spinal cord injury, traumatic brain injury (concussion, impact, and penetrating brain wounds), brain 
cancers and rare monogenic metabolic disorders. Several of these approaches are considered in 
later chapters of this volume. For some of the cited applications there is a rational mechanism for 
repair, for most, however, the pre-clinical data are still not sufficiently convincing to warrant 
progression to a clinical trial. A good example, where the underlying experimental validation is 
sufficiently clear, relates to the application of surgical replacement of the supportive retinal pigment 
epithelium in eye diseases related to macular degeneration. Several groups have now developed 
effective protocols for differentiation of PSCs to a retinal pigment epithelium cell phenotype 
(Buchholz et al., 2013), and at least three stem cell-based cell therapies are underway in USA, Japan 
and the UK. Injection of hPSC-RPE suspensions have not achieved optimal functionally integration. 
However, with good preclinical evidence of efficacy, seeding the cells on an artificial matrix to 
provide transplantable monolayer sheets are now entering clinical trial in the ‘London Project to 
Cure Blindness’ (Ramsden et al., 2016), as described by Peter Coffey (Chapter 22) in this volume.  
These trials are still at a very early stage. However as we go to press, there is considerable and 
widespread optimism – albeit, as yet unproven – that the neural transplantation field is at a stage of 
transition from long-lasting but uncritical promise, to the advent of a new era of effective, evidence-
based cell therapies for a broad range of hitherto untreatable neurodegenerative diseases and 
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conditions. Only time and evidence, based on high quality critical science, will establish whether 
such optimism is justified. 
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Tables 
Table 1. Mechanisms of Graft Function of Greater or Lesser Neuronal Specificity. 
Mechanism Explanation 
1. Nonspecific or negative 
effects of surgery 
Surgical, mechanical or traumatic injury caused by the implantation 
surgery including space occupying lesions and transplant overgrowth 
2. Positive effects of surgical 
lesions * 
Surgical damage (rarely) provides a positive effect, such as provided by the 
‘rebalancing’ of output pathways following lesions or deep brain 
stimulation in Parkinson’s disease 
3. Bystander effects * Non-neuronal effects, esp. of undifferentiated stem cells, to reduce scar 
formation, promote neuroprotection and modulate the immune 
environment. 
4. Trophic stimulation  Implants deliver exogenous trophic factors that enhance neuronal survival, 
plasticity, axon sprouting and regeneration within host neurons. 
5. Target support of host 
projections 
Implanted tissues provide new or replacement targets for host axons, 
preventing die back following endogenous target loss. 
6. Structural glial support * Glial cell replacement provides structural, metabolic and functional 
support for endogenous or exogenous neuronal networks. 
7. Pharmacological Diffuse release of deficient neurotransmitters, hormones or signalling 
molecules acting at tonic levels on host neurons. 
8. Diffuse reinnervation Implanted cells establish synaptic contacts with host targets, with synaptic 
release of deficient neurotransmitters at physiological concentrations, and 
with potential of local presynaptic feedback regulation. 
9. Passive bridges Cellular grafts provide substrates for stimulation and guidance of axonal 
(re-)growth, across lesions, from host or graft neurons.  
10. Active bridges Grafted neurons provide a trans-synaptic relay of communication between 
host targets 
11. Reciprocal graft-host 
reinnervation 
Implanted neurons become incorporated into the host neuronal network 
to restore information processing capacity beyond simple relay. 
12. Full reconstruction  Reconstruction of all aspects of the damaged host network for full 
restoration and repair of normal circuit processes. 
Based on table in Dunnett and Bjorklund, Neural Transplantation (Dunnett & Björklund, 1994b), see 
text for examples 
* Italics: Mechanism added subsequent to the 1994 table. 
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Figure legends 
Figure 1.  Schematic illustration of denervation and circuit repair in ectopic 6-OHDA/VM lesion/graft 
model and in the homotopic EAA/WGE model. Abbreviations: 6-OHDA, 6-
hydroxydopamine; CPu, caudate-putamen (‘striatum’); Ctx, neocortex; EAA, excitotoxic 
amino acid; GP, globus pallidus; NSP, nigrostriatal pathway; SN, substantia nigra; VM, 
ventral mesencephalon; WGE, whole ganglionic eminence. 
 
Figure 2.  Behavioural and physiological evidence of relearning and long term plasticity. A, schematic 
diagram of the 9-hole box operant test apparatus. B, initial acquisition of lateralised choice 
reaction time task, performance abolished by striatal lesions, and relearned in the 
presence of an established transplant (Brasted et al., 1999c, Brasted et al., 1999b). C, 
schematic diagram of the oblique brain slice used to record synaptic plasticity at the 
corticostriatal graft-host synapse. D, comparable LTD at the corticostriatal synapse in both 
intact and grafted striatum. E, transformation to LTP in both groups in Mg-free media. 
Similar patterns of long term plasticity were described using both extracellular and 
intracellular recordings (Mazzocchi-Jones et al., 2009). 
 
Figure 3. Fiber outgrowth from fetal cholinergic neurons transplanted to the hippocampus in adult 
rats. The tissue was obtained from the basal forebrain of E16 rat embryos and 
transplanted either as a solid piece into a pre-formed cavity transecting the fornix-fimbria 
(FF) pathway (A), or as a cell suspension injected into the dorsal and ventral hippocampus 
(B). C. Acetylcholinesterase (AChE) staining of the normal hippocampal innervation, loss 
following fimbria fornix lesion, and extensive reinnervation in laminar specific distribution 
by a solid septal graft. D. Functional recovery in T maze learning associated with solid and 
suspension grafts in the hippocampus. E. Photomicrographs of AChE staining showing that 
the distribution and laminar patterning of the graft-derived fibers in hippocampus and 
dentate gyrus (right panel) match closely the normal laminar innervation patters (left). 
Data derived from   (Björklund & Stenevi, 1977, Dunnett et al., 1982, Nilsson et al., 1990a). 
See text for further details. 
 
 
Figure 4. Bridge models. Schematic illustration of alternative strategies for bridge grafting. A,B, in 
the spinal cord. C,D, in the nigrostriatal pathway. E,F, in the septo-hippocampal circuit. See 
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